Dr. Minturn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3501 Civic Center Blvd, ARC 1354
Children's Hospital Of Philadelphia - Hem/Onc
Philadelphia, PA 19104Phone+1 215-590-2299Fax+1 215-590-3296
Summary
- Dr. Jane Minturn is a pediatric hematologist/oncologist in Philadelphia, PA and is affiliated with Children's Hospital of Philadelphia. She received her medical degree from Yale University School of Medicine and has been in practice 21 years. She specializes in pediatric neuro-oncology.
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1999 - 2002
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1996 - 1999
- Yale School of MedicineClass of 1996
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2021 - 2026
- DE State Medical License 2022 - 2025
- MD State Medical License 2021 - 2025
- NC State Medical License 2021 - 2025
- NJ State Medical License 2022 - 2025
- PA State Medical License 1999 - 2024
- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Clinical Trials
- Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
- Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
- Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
- Join now to see all
Publications & Presentations
PubMed
- 179 citationsResistance to Chemotherapy Mediated by TrkB in NeuroblastomasRuth Ho, Angelika Eggert, Tomoro Hishiki, Jane E. Minturn, Naohiko Ikegaki
Cancer Research. 2002-11-15 - 53 citationsPhase I study of vemurafenib in children with recurrent or progressive BRAFV600E mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002).Theodore Nicolaides, Kellie J. Nazemi, John Robertson Crawford, Lindsay Kilburn, Jane E. Minturn
Oncotarget. 2020-05-26 - 18 citationsRisk of brainstem necrosis in pediatric patients with central nervous system malignancies after pencil beam scanning proton therapyJ. Vogel, A. Grewal, Shannon O'Reilly, Robert A. Lustig, G. Kurtz
Acta Oncologica. 2019-09-12
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: